Donate
Skip Navigation Links
  Health care providers
 • Treating psoriasis
 • Working with plans
 • For your patients
 • Pro. membership
 • Provider Directory
 • Forum Journal
 • Events for Providers
Residents Meeting
Apply
Faculty Bios
Travel/Lodging


Publications

Psoriasis Forum Journal

The National Psoriasis Foundation journal Psoriasis Forum, published quarterly, is the only publication of its kind—dedicated to providing up-to-date and practical information to health care providers on the front line of psoriasis treatment.

Psoriasis Forum is sent to professional members of the Psoriasis Foundation.

Become a professional member today »


Current issue: Spring 2012 Vol. 18, No. 1

Featured article

A Review of Drugs That Induce or Exacerbate Psoriasis

Julie Hong, Daniel Bernstein, BS

ABSTRACT
Background: Psoriasis is a common disorder of the skin, immune system, and joints that is influenced by genetic and environmental factors. It can be aggravated or induced by drugs.
Objectives: To identify the major drugs implicated in inducing or exacerbating psoriasis and to discuss their characteristics.
Methods: We performed a PubMed literature search for reviews and case reports on drugs that exacerbate or induce psoriasis.
Articles were screened by title and abstract and then examined for their findings and references.
Results: Drugs most often reported to exacerbate or induce psoriasis were β-blockers, lithium, synthetic antimalarials, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, interferons, tetracyclines, tumor necrosis factor-α inhibitors, and steroid withdrawal.
Conclusions: Characterizing drugs that induce or exacerbate psoriasis by latency and type of psoriatic eruption can help guide clinical reasoning. Although a relatively uncommon occurrence, psoriatic lesions can be caused by drugs, allowing astute physicians to recognize and change their management plans accordingly.

Download the full article »

Also in this issue:

  • The Unique Impact of Psoriasis on the Geriatric Population: A Review
  • The Role of Stress in Children with Psoriasis
  • Naphthalan Oil in the Treatment of Psoriasis and Psoriatic Arthritis
  • Treatment of Psoriasis During Pregnancy
  • Recurrent Erythema Multiforme in a 63-Year-Old Woman Undergoing Biologic Therapy
  • Optimizing the Approval Pathway for Biosimilars to Treat Psoriasis and Psoriatic Arthritis

Online access to current and past issues of Psoriasis Forum is available to professional members.

Want to read more? Become a professional member


National Psoriasis Foundation

Mission: Working to find a cure for psoriasis and psoriatic arthritis and to eliminate their
devastating effects through research, advocacy and education.

Contact us:
Email: getinfo@psoriasis.org
800.723.9166

6600 SW 92nd Ave.,
Suite 300
Portland, OR 97223


Special sections:

About us:

Find us online:

NPF receives 4-star rating from Charity NavigatorCopyright © 2012 National Psoriasis Foundation/USA
Privacy policy | Terms of use | Sitemap

The National Psoriasis Foundation does not endorse or
accept any responsibility for the content of external websites.